Navigation Links
Cystic Fibrosis Foundation President Rings Bell to Close New York Stock Exchange
Date:5/13/2008

Federal Realty Investment Trust invites Foundation to celebrate scientific advancements that have fueled longer life for people with CF

BETHESDA, Md., May 13 /PRNewswire-USNewswire/ -- To celebrate remarkable progress in treating cystic fibrosis -- a fatal genetic disease -- Federal Realty Investment Trust invited the Cystic Fibrosis Foundation to join the company as honored guests of the New York Stock Exchange (NYSE) today.

Life expectancy for people with CF has more than doubled in the past 25 years, as a result of scientific advances fueled by the Foundation. When the Foundation was established in 1955, few children with the disease lived to attend elementary school. Today, the median predicted age of survival for people with CF is 37 years.

In recognition of the Foundation's achievements and National CF Awareness Month, Robert J. Beall, Ph.D., president and CEO of the Foundation and Donald Wood, president and CEO of Federal Realty Investment Trust, rang the NYSE bell signaling the close of the market at 4:00 P.M today.

"We are pleased and honored to take part in this distinguished NYSE tradition," said Beall. "People with cystic fibrosis are living longer than ever, and we are excited about this tremendous progress. At the same time, there is much work to be done in the fight against this devastating disease."

To advance the search for a cure, the Foundation has built a "pipeline of promise" with more than 30 therapies in development for cystic fibrosis, and invested nearly $300 million in CF research in the biotech industry since 1998. For the first time in the history of the disease, the Foundation's pipeline has drugs under development that target the root causes of cystic fibrosis -- not just the symptoms. If successful, these therapies will add decades of life for people with CF.

Virtually every approved CF drug available today was made possible because of Foundation support. Since the 1980s, the Foundation has played an integral role in the development of Pulmozyme, TOBI, azithromycin and hypertonic saline for use as CF treatments.

"This is truly an exciting time for the CF community, with so many promising therapies in development," said Federal Realty Investment Trust president and CEO Donald Wood. "We are more passionate than ever about the Foundation's critical work to cure and control cystic fibrosis."

Federal Realty Investment Trust is an equity real estate investment trust specializing in the ownership, management, development, and redevelopment of high quality retail assets. Federal Realty is an S&P MidCap 400 company and its shares are traded on the NYSE under the symbol FRT.

About the Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the leading organization in the United States devoted to curing and controlling cystic fibrosis. Headquartered in Bethesda, Md., the Foundation has more than 80 chapters and branch offices throughout the country and supports and accredits a nationwide network of 115 care centers, which provide vital treatments and other CF resources to patients and families. For more information, visit http://www.cff.org.


'/>"/>
SOURCE Cystic Fibrosis Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ibuprofen can slow lung disease in children with cystic fibrosis, Canadian study shows
2. Anaheim to Host Worlds Largest Cystic Fibrosis Medical Meeting
3. AMRI and Cystic Fibrosis Foundation Launch Major Research Collaboration
4. Cystic Fibrosis Foundation Named Charitable Organization of the Year by USA Track & Field
5. Cystic Fibrosis foundation lays out new treatment guidelines
6. Experts Release New Cystic Fibrosis Guidelines
7. Lung Transplants May Not Help Most Cystic Fibrosis Children
8. Ibuprofen associated with slower lung function decline in children with cystic fibrosis
9. Ibuprofen Preserves Lung Function in Kids With Cystic Fibrosis
10. Montana Passes Newborn Screening Law for Cystic Fibrosis
11. Cystic Fibrosis Foundation reports upward trend for key health outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... ... July 25, 2017 , ... ... provider in the United States, today announced its partnership with financial technology company, ... , The foundation of the solution lies within Hyosung’s superior ATMs, assisted self-service ...
(Date:7/24/2017)... , ... July 24, 2017 , ... Engineers at the ... because it produces the same kind of electrical energy that the body uses. ... of moving electrons. This flow of electrons out of the battery is generated by ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted Response to ... Department of Health Care Services, will facilitate the development of a hub and ...
(Date:7/24/2017)... ... 2017 , ... Every year, thousands of dedicated Higher Education and K12 professionals ... is coupled with a dynamic theme like Camp Canvas; this year, they’ve managed to ... , To extend their partnership with Canvas beyond the LMS integration, Modo Labs ...
(Date:7/24/2017)... Solana Beach, California (PRWEB) , ... July 24, ... ... and commercialization of autologous fat (adipose) transfer systems announces the issuance of United ... (the ‘324 patent) for its adipose filtration technology. The '398 and '324 ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... 24, 2017 IBM (NYSE: IBM ) has ... for Solid-State Arrays (SSA) for the fourth year in a ... to Gartner, "Vendors in the Leaders quadrant have the highest ... A vendor in the Leaders quadrant has the market share, ... acceptance of new technologies. These vendors demonstrate a clear understanding ...
(Date:7/21/2017)... Did you know that PhRMA member companies invested $65.5 ... spending on brand medicines, generics and the supply chain account for ... just half of this (7 percent)? Or that the ... venture capital investments in high-growth biopharmaceutical startups? ... The biopharmaceutical ...
(Date:7/14/2017)... 14, 2017 Endo International plc (NASDAQ: ENDP ... 8, 2017.  Members of its senior management team will host a ... 8:30 a.m. ET. The dial-in number to access ... (678) 509-7598, and the passcode is 45397076. Please dial in 10 ... A replay of the call will be available ...
Breaking Medicine Technology: